|
|
||||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
1 The Motherisk Program, Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children and University of Toronto, Toronto, Canada
2 Department of Neonatology, Hadassah Medical Center and The Hebrew University, Jerusalem, Israel
Correspondence to:
Correspondence to:
Dr Koren, Director, Motherisk Program, Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada;
gkoren{at}sickkids.ca
Background: Meconium and hair are two biological markers of in utero exposure to illicit drugs.
Objective: To compare the sensitivity of the two tests for different drugs.
Setting: Motherisk laboratory which tests in utero drug exposure in Toronto.
Methods: Cocaine, benzoylecgonine, opiates, cannabis, benzodiazepines, methadone, and barbiturates were measured in pairs of hair and meconium samples from the same neonates.
Results: Meconium was marginally more sensitive than neonatal hair for detection of cocaine and cannabis, possibly because it may detect second trimester exposure whereas hair grows only during the third trimester of pregnancy. There was a significant correlation between hair and meconium concentrations of cocaine, cannabis, and opiates.
Conclusion: In cases of clinical suspicion and a negative neonatal urine test, both meconium and hair are effective biological markers of in utero illicit drug exposure. Meconium may be more sensitive, but neonatal hair is available for three months whereas meconium is available for only one or two days. In contrast, the use of meconium, being a discarded material, is more acceptable to some parents than hair testing, which entails cutting scalp hair from the newborn.
Keywords: drug exposure; hair analysis; meconium analysis
Relevant Article
Arch. Dis. Child. Fetal Neonatal Ed. 2003 88: F80.
This article has been cited by other articles:
![]() |
F. Garcia-Bournissen, F. Asrar, Z. Verjee, T. Karaskov, and G. Koren Contamination of Hair With 3,4-Methylene Dioxymethamphetamine (Ecstasy) in 2 Young Girls from a "Meth Lab" Clinical Pediatrics, March 1, 2008; 47(2): 186 - 188. [PDF] |
||||
![]() |
R. S. Goodwin, D. G. Wilkins, O. Averin, R. E. Choo, J. R. Schroeder, D. R. Jasinski, R. E. Johnson, H. E. Jones, and M. A. Huestis Buprenorphine and Norbuprenorphine in Hair of Pregnant Women and Their Infants after Controlled Buprenorphine Administration Clin. Chem., December 1, 2007; 53(12): 2136 - 2143. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Garcia-Bournissen, B Rokach, T Karaskov, and G Koren Methamphetamine detection in maternal and neonatal hair: implications for fetal safety Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2007; 92(5): 351 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
J A Ortega Garcia, D Carrizo Gallardo, J Ferris i Tortajada, M M P Garcia, and J O Grimalt Meconium and neurotoxicants: searching for a prenatal exposure timing Arch. Dis. Child., August 1, 2006; 91(8): 642 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Williamson, L Jackson, C Skeoch, G Azzim, and R Anderson Determination of the prevalence of drug misuse by meconium analysis. Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2006; 91(4): F291 - F292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Abdel-Latif, J. Pinner, S. Clews, F. Cooke, K. Lui, and J. Oei Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics, June 1, 2006; 117(6): e1163 - e1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
C A Kuschel, L Austerberry, M Cornwell, R Couch, and R S H Rowley Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome? Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2004; 89(5): F390 - F393. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chan, J. Klein, and G. Koren New Methods for Neonatal Drug Screening NeoReviews, September 1, 2003; 4(9): e236 - 244. [Full Text] [PDF] |
||||
![]() |
H. Marcovitch BMJ family highlights BMJ, April 12, 2003; 326(7393): 785 - 785. [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| ARCH DIS CHILD | FETAL NEONATAL ED | ED PRACTICE |